BIOVAXYS APPOINTS FORMER SANOFI VACCINES EXECUTIVE TO BOARD OF DIRECTORS
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 08 2025
0mins
Should l Buy ?
Source: PRnewswire
New Board Appointment: BioVaxys Technology Corp. has appointed Dr. James Tartaglia, a former executive at Sanofi Vaccines, to its Board of Directors, filling a vacancy left by Anthony Dutton's resignation.
Dr. Tartaglia's Expertise: With over 34 years in vaccine R&D, Dr. Tartaglia has been instrumental in the development and licensure of numerous vaccines and will contribute his extensive experience to BioVaxys's vaccine programs.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
